Agilis Robotics develops flexible robotic instruments for endoluminal surgery.
Agilis Robotics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Agilis Robotics's investors include K2VC, Korea Investment Partners.
Agilis Robotics is headquartered in Sha Tin, Hong Kong.
Agilis Robotics develops flexible robotic instruments for endoluminal surgery.
Agilis Robotics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Agilis Robotics — Funding & Investors." VCBacked, March 20, 2024, https://www.vcbacked.co/company/agilis-robotics. Accessed October 29, 2026.
VCBacked. (2024). Agilis Robotics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/agilis-robotics
{{cite web |title=Agilis Robotics — Funding & Investors |url=https://www.vcbacked.co/company/agilis-robotics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated